NCT00996073View on ClinicalTrials.gov

Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2014

Conditions
Degenerative Disc DiseaseDegenerative SpondylolisthesisSpinal Stenosis
Interventions
BIOLOGICAL

Lumbar Interbody Fusion with Autograft

Single Dose Autograft Surgical Implantation

BIOLOGICAL

Lumbar Interbody Fusion with NeoFuse

Single Dose NeoFuse Surgical Implantation

BIOLOGICAL

Lumbar Interbody Fusion with NeoFuse

Single Dose NeoFuse Surgical Implantation

Trial Locations (5)

46804

Fort Wayne Orthopaedics, Fort Wayne

78731

Central Texas Spine Institute, Austin

80111

Denver Spine, Greenwood Village

80538

Rocky Mountain Associates in Orthopedic Medicine, P.C., Loveland

90404

The Spine Institute, Santa Monica

Sponsors

Lead Sponsor

Mesoblast, Ltd.
All Listed Sponsors
lead

Mesoblast, Ltd.

INDUSTRY

NCT00996073 - Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion | Biotech Hunter | Biotech Hunter